A pharmacist exposes the shocking reality of drug pricing, revealing how a cancer medication that costs just $7 to buy ends up costing Medicare $2,400 per prescription. At a local pharmacy, a small $10 markup means patients can get the drug for $17—yet when Medicare steps in, the price explodes. With 250,000 prescriptions filled in a single year, taxpayers were hit with a $600 million bill.

"If every one of those prescriptions had been filled at our pharmacy instead of through Medicare, the total cost would’ve been just $4 million—a mind-blowing $596 million less. That’s crazy," the pharmacist explains.

So why the massive price gap? The answer lies with Pharmacy Benefit Managers (PBMs)—the middlemen who control drug pricing for insurance companies. Just three PBMs dominate 90% of the U.S. prescription market, and all of them have been bought out by pharmaceutical companies. This monopoly lets them inflate prices at will, forcing Medicare to overpay while taxpayers pick up the tab.

Not your average climate change activists — these ones come with a little extra.